Early Outcomes and Toxicity with Concurrent Chemotherapy and Hypofractionated Radiation Therapy in Patients with Non-Small Cell Lung Cancer

被引：0
|
作者：
Hui, Caressa [1 ]
Marquez, Cesar [1 ]
Lau, Brianna [1 ]
Von Eyben, Rie [1 ]
Das, Millie [1 ]
Myall, Nathaniel [1 ]
Roy, Mohana [1 ]
Chin, Alex [1 ]
Diehn, Maximilian [1 ]
Loo, Billy [1 ]
Vitzthum, Lucas [1 ]
机构：
[1] Stanford Univ, Stanford, CA USA
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2022年 / 45卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P43
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Accelerated Hypofractionated Radiation Therapy in Early-Stage Non-small Cell Lung Carcinoma With Concurrent Chemotherapy
    Bhavsar, S. K.
    Mann, J. M.
    Gajra, A.
    Bogart, J. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S595 - S595
  • [2] Outcomes of Hypofractionated Radiation Therapy (HFRT) with Concurrent Chemotherapy in Patients with Stage III Non Small Cell Lung Cancer (NSCLC)
    Shepherd, A.
    Gelblum, D.
    Wu, A.
    Rimner, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S661 - S662
  • [3] Use of Hypofractionated Radiation Therapy With Concurrent Chemotherapy in Inoperable Stage II/III Non-small Cell Lung Cancer
    Kim, E.
    Westover, K. D.
    Daly, M. E.
    Murphy, J. D.
    Mitin, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E468 - E468
  • [4] Hypofractionated vs Conventionally Fractionated Radiation Therapy with Concurrent Chemotherapy for Stage III Non-small Cell Lung Cancer
    Sasse, Alexander
    Jairam, Vikram
    Saeed, Nadia
    Park, Henry
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S109 - S110
  • [5] Toxicity of Hypofractionated Accelerated Radiotherapy Concurrent with Chemotherapy for Non-small Cell Carcinoma of the Lung
    Carruthers, R.
    O'Rourke, N.
    Mohammed, N.
    Hicks, J.
    Brisbane, I.
    CLINICAL ONCOLOGY, 2011, 23 (08) : 561 - 562
  • [6] Oesophageal Toxicity and Hypofractionated Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer
    Tho, L. M.
    Mahmood, R.
    Leitch, M.
    Brisbane, I.
    Kakumanu, S.
    Mohammed, N.
    CLINICAL ONCOLOGY, 2009, 21 (01) : 74 - 74
  • [7] Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non-Small-Cell Lung Cancer
    Hui, Caressa
    Marquez, Cesar
    Lau, Brianna
    Das, Millie
    Myall, Nathaniel J.
    Roy, Mohana
    Wakelee, Heather A.
    Neal, Joel W.
    Kovalchuk, Nataliya
    Chin, Alex
    Diehn, Maximilian
    Loo, Billy W., Jr.
    Xiang, Michael
    Vitzthum, Lucas K.
    CLINICAL LUNG CANCER, 2024, 25 (02) : e92 - e100.e4
  • [8] Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer
    Sergio L Faria
    Luis Souhami
    Lorraine Portelance
    Marie Duclos
    Te Vuong
    David Small
    Carolyn R Freeman
    Radiation Oncology, 1
  • [9] Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer
    Faria, Sergio L.
    Souhami, Luis
    Portelance, Lorraine
    Duclos, Marie
    Vuong, Te
    Small, David
    Freeman, Carolyn R.
    RADIATION ONCOLOGY, 2006, 1 (1)
  • [10] Outcomes of Hypofractionated Radiation Therapy in Poor Risk Non-small Cell Lung Cancer Patients and Validation of RTOG 0213
    Guo, S.
    Reddy, C. A.
    Stephans, K. L.
    Videtic, G. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S564 - S565
12345